The Wylie Scholar Program

provides 3-year career development grants to outstanding young vascular surgeon-scientists who combine active patient care with academic research.

The award supports crucial research that enables them to compete for future research funding. Wylie Scholars become North America’s world-class vascular surgeon-scientists; many are now chiefs at major academic centers, prominent leaders in the field, and play a key role in our programs.

Since 1996, we’ve established a group of 24 surgeon-scientists at 15 institutions around the country who are transforming patient care. Each year, the new grantee is selected by a committee of previous Wylie Scholars. The quality and rigor of the selection process are demonstrated by the fact that the average return on investment for follow-on research funding is 30:1.

Impact

For each $150,000 award,

Wylie Scholars have generated $4.4 million in subsequent national research funding:

A return on investment of nearly 30 to 1.

To read more about the impact of the Wylie Scholar program,

Wylie Scholar Award

Research Highlights

Wylie Scholars continue to advance new cures and treatments.
For example:

Dr. Mohamed Zayed,

Washington University, is investigating why diabetics develop a unique lipid profile leading to peripheral artery disease, one of the most common and most expensive vascular diseases. His progress has been presented at several American Heart Association meetings.

Dr. Katherine Gallagher,

University of Michigan, is studying impaired wound healing to design novel therapeutic agents for the treatment of these wounds, looking specifically at the role of stem cells from bone marrow.

Dr. Bryan Tillman,

Ohio State University, is developed a retrievable stent that will improve the ability of non-vascular surgeons to manage life-threatening injuries. In 2016, he received a $2.5 million contract from the Department of Defense to use this technology to treat severe bleeding in the torso for wounded soldiers on the battlefield.

Dr. Matthew Corriere,

University of Michigan, is developing a tool for doctors to understand patient goals and improve shared decision-making in vascular treatment. He is working to understand the benefits of increasing patient participation and engagement in their own care, and was the leader of Vascular Cures’ Project Voice, a program focused on patient-reported outcomes research and patient empowerment.

Award Details

The Wylie Scholar 2023 Award Application will be available later this year.

Vascular Cures will award each Wylie Scholar $50,000 per year for up to three years,

subject to an annual review by the committee. Payment of awards will be made to the candidate’s institution and the institution will be responsible for disbursing all funds and for the administration of the grant. Vascular Cures does not pay indirect costs.

Award Uses

The award may be used to support research in the following areas:

Basic science, translational, clinical research, outcomes/health services research, teaching, community service, and patient care.

Eligibility

Candidates must hold a full-time faculty appointment as a vascular surgeon with active privileges at a medical school accredited by the Liaison Committee on Medical Education in the United States or the Committee for the Accreditation of Canadian Medical Schools in Canada.

The candidate must be an active, practicing clinical vascular surgeon.

The following conditions also must be met:

  • The candidate must hold a valid and current certification from the American Board of Surgery, or the Royal College of Physicians and Surgeons of Canada, in general surgery or vascular surgery.
  • The candidate must present convincing evidence of rigorous research training and significant research accomplishments to date.
  • The Wylie Scholar Program is intended to support outstanding vascular surgeon scientists in the initial phases of their academic careers to accomplish the groundwork needed to be competitive for national career development awards or other independent funding.
    The candidate must not be currently funded by any of these career development awards:
    • Veterans Affairs CDA or RDA or alternatively named program with similar level of funding
    • American Heart Association, or similar extramural funding agencies
    • NIH R01 or R21
    • Individual K awards (KL2 institutional awards are not disqualifiers)
  • The candidate must disclose prior and existing individual awards and/or funds received to support their research. Concomitant awards similar in size to the Wylie Scholar will be considered on an individual basis.

    Examples include:

    • Awards from professional societies such as the American College of Surgeons
    • Young faculty awards via professional societies
    • NIH small grant program R03
  • The candidate must prepare and present a challenging research plan to be completed during the term of the award.
  • The candidate must have a research mentor who will be an additional resource for his or her research.
  • The Chairman of the Department of Surgery must guarantee that the candidate will have 40% protected time available to devote to the research investigation, as well as facilities, equipment, and resources to execute the proposed studies.
  • The candidate is expected to participate in one Vascular Cures event each year during their research grant tenure, during which they will meet with the Vascular Cures CMO to support the scientific mentorship and training. Vascular Cures will discuss and decide which event is most appropriate with the awardee. Up to $2,000 of the annual stipend may be used for travel expenses and two nights of lodging.

Evaluation

The Wylie Scholar Award Committee, made of up former Wylie Scholars,

will select the Scholar and present their recommendation to the Vascular Cures Chief Medical Officer for final approval.

The key criteria for selection of the potential Wylie Scholar will be a demonstrated aptitude for and interest in vascular research, skill and promise in vascular surgery, teaching ability, and leadership qualities.

Wylie Scholars

Tammy T. Nguyen, MD, PhD 2022

Dr. Tammy Nguyen received the 2022 Wylie Scholar Award for her project “Exploring How the Diabetic Immune System Contributes to Non-Healing Ulcers”.  Type 2 diabetic (T2D) patients have a thirty-fold increased lifetime risk of developing a foot ulcer, of which 50%...

Kevin W. Southerland, MD 2021

Dr. Kevin Southerland received the 2021 Wylie Scholar Award for his project “Transcriptional Dynamics and Heterogeneity of Macrophages in Chronic Limb Threatening Ischemia”. Chronic limb-threatening ischemia (CLTI) is the most severe manifestation of peripheral...

Kathryn Howe, MD, PhD 2020

Dr. Kathryn Howe received the 2020 Wylie Scholar Award for her project “Role of endothelial extracellular vesicle microRNA release and paracrine cellular communication in vulnerable carotid atherosclerotic plaques: a new paradigm for stroke.” Many people have...

Andrea Obi, MD 2019

Dr. Andrea Obi received the 2019 Wylie Scholar Award for her work on “Impact of bone marrow progenitor cells epigenetic memory on venous thrombus formation and resolution”. Her lab seeks to better understand how blood clots in our veins form, the root cause of...

John Byrne, MD 2018

Dr. John Byrne received the 2018 Wylie Scholar Award for his work on “Characterization of Macrophage Biology in the Pathogenesis of Abdominal Aortic Aneurysms.” His research will study the inflammatory process of abdominal aortic aneurysm (AAA) development, which...

Sean English, MD 2017

Dr. Sean English became the 20th Wylie Scholar for his research project to neutralize the body’s signaling mechanisms which cause abdominal aortic aneurysms (AAA). Abdominal aortic aneurysm (AAA) represents an important medical and surgical disease process, and AAA...

Ryan McEnaney, MD 2016

Dr. Ryan McEnaney received the 2016 Wylie Scholar Award for his research on the development of medical therapies to unblock arteries for patients for whom surgical procedures are not an option. Diseases involving arterial blockages are the leading causes of death and...

Mohamed Zayed, MD, PhD 2015

Mohamed Zayed received the 2015 Wylie Scholar award for his research on the role of phospholipids in the progression of peripheral arterial disease in the setting of diabetes. Patients afflicted with chronic diabetes are more likely to develop occlusions in the...

Matthew Corriere, MD 2014

The Wylie Award supports Dr. Corriere’s research aimed at increasing participation of patients with peripheral arterial disease (PAD) in their own care by enabling providers to involve them in treatment decisions. PAD affects over 8.5 million Americans, including over...

Thomas Monahan, MD 2013

Vascular Cures mourns the loss of Dr. Monahan, a great contributor to vascular surgery through both his academic research and clinical practice. More information on Dr. Monahan’s life can be found here. The Wylie Grant was awarded to support Dr. Monahan’s research...

Katherine Gallagher, MD 2012

Diabetic wounds represent a significant health problem and are currently the leading cause of non-traumatic amputation in the United States. In an effort to address this problem, Dr. Gallagher is studying impaired wound healing in diabetes in order to design novel...

Gale Tang, MD 2011

The Wylie grant was awarded to support Dr. Tang’s research in understanding the mechanisms that promote blood vessel growth, and to develop new non-surgical therapies for people suffering from an advanced form of peripheral artery disease (PAD). As a vascular surgeon,...

Bryan Tillman, MD, PhD 2010

As a clinician-scientist, Dr. Tillman’s research investigates how a particular type of stem cell in the blood leads to recurrent blockage after a stent or bypass graft. This disease is responsible for failure of over half of all vascular interventions in less than...

Ulka Sachdev, MD 2008

Dr. Sachdev’s research involves understanding the mechanisms that promote blood vessel growth (angiogenesis) and developing new therapies for people suffering from peripheral arterial disease (PAD) and critical limb-threatening ischemia (CLTI). PAD, a vascular disease...

Matthew Eagleton, MD 2007

Dr. Eagleton is investigating the processes leading to the development of an abdominal aortic aneurysm, a potentially fatal bulge or ballooning of the main artery leading from the heart to lower portions of the body. Currently, the only available treatment for aortic...

Eric Choi, MD 2006

Dr. Choi’s research involves vein and artery complications in patients undergoing dialysis due to kidney failure. Chronic kidney disease, often caused by high blood pressure or diabetes, affects one in nine Americans, with another 20 million at increased risk....

Rajabrata Sarkar, MD, PhD 2005

Dr. Sarkar is investigating the genetic mechanisms regulating the growth of new arteries and ways to prevent damage from blood clots in the veins. Deep vein thrombosis (DVT), affects more than 2 million Americans and contributes to 200,000 deaths each year by causing...

Michael Watkins, MD 2004

Dr. Michael T. Watkins worked on developing new ways to repair thoracic aortic aneurysms, as well as addressing complications that occur after restoring blood flow in patients with critical limb ischemia. Thoracoabdominal aneurysms are particularly difficult to treat....

Paul DiMuzio, MD 2003

Dr. DiMuzio is using adult stem cells and advanced tissue-engineering technology to create new blood vessels for bypass grafts. Although veins are usually used for bypass grafts, not all patients have enough of their own tissue to use in this way. Dr. DiMuzio has...

Alan Dardik, MD 2002

Blocked arteries can happen throughout the body and may require surgical interventions, such as creating bypass vein grafts and performing angioplasties to restore blood flow. However, up to half of angioplasties fail within one to two years, and vein grafts fail at a...

Edith Tzeng, MD 2001

Dr. Tzeng is at the forefront of developing treatments to treat abnormal cell growth following angioplasty. Angioplasty is a type of surgery that uses a small balloon guided with a catheter to open blocked arteries. The balloon is inflated when it reaches the...

Richard Powell, MD 1999

Dr. Powell is currently leading an international clinical trial to evaluate a new type of stent for patients with advanced peripheral artery disease (PAD). He also is working on two clinical trials involving gene and stem cell therapies to prevent limb amputation in...

Barry Rubin, MD, PhD 1998

Dr. Rubin is exploring the way the heart responds to injury and the regulation of the immune response to infection. His research has been widely published in high impact journals. Dr. Rubin and his laboratory continue to investigate the role of prostaglandins in left...

Larry Kraiss, MD 1997

Larry Kraiss, MD is investigating a new treatment for patients with kidney disease who need dialysis, and is involved in a clinical trial of a drug that may reduce the rate of aneurysm growth. As a Wylie Scholar, Dr. Kraiss studied how endothelial cells that line the...

Robert Thompson, MD 1996

Dr. Robert Thompson’s research is focused on the cellular and molecular mechanisms responsible for the growth of abdominal aortic aneurysms. Through the support of the Wylie Scholar award, he has identified a group of enzymes that break down the connective tissue in...